Fresenius SE & Co KGaA AAQS 2024
Fresenius SE & Co KGaA AAQS
Ticker
ISIN
WKN
Fresenius SE & Co KGaA omab hetkel AAQS väärtuseks 2. Kõrget AAQS-i võib pidada positiivseks märgiks, et ettevõte areneb edukalt. Investorid võivad eeldada, et ettevõte on heas seisus kasumi teenimiseks. Teisest küljest on oluline vaadelda Fresenius SE & Co KGaA aktsia AAQS-i võrdluses saadud kasumite ja sama sektori teiste ettevõtetega. Kõrge AAQS ei ole absoluutne garantii positiivseks tulevikuks. Ainult nii on võimalik saada täielik ülevaade ettevõtte sooritusest. Ettevõtte arengu paremaks hindamiseks on oluline võrrelda AAQS-i sama sektori teiste ettevõtetega. Üldiselt peaksid investorid alati vaatlema ettevõtte AAQS-i seoses teiste näitajatega nagu kasum, EBIT, rahavoog ja muud, et teha põhjendatud investeerimisotsus.
Fresenius SE & Co KGaA Aktienanalyse
Mis teeb Fresenius SE & Co KGaA?
Fresenius SE is a German pharmaceutical and medical technology company, which was founded in 1912 by Eduard Fresenius. The company's history is marked by continuous growth and numerous acquisitions, which have shaped the current corporate structure. Fresenius operates in four different divisions: Fresenius Medical Care is a global leader in dialysis treatment and offers products as well as services related to dialysis. Fresenius Kabi specializes in the production of medications and medical devices for infusion and nutrition therapy. Fresenius Helios is one of the largest providers of hospital treatments with over 110 clinics and operates facilities in Germany, Spain, and Latin America. Fresenius Vamed offers services related to the management and planning of healthcare facilities and operates worldwide in over 85 countries. The business model of Fresenius SE is based on the development and production of innovative medical products, as well as the provision of services in the healthcare sector. The company relies on high-quality products and intensive research and development. A key factor for success is focusing on the needs of customers and patients to ensure the best possible care. One of the most well-known products of Fresenius SE are the Fresenius concentrates for dialysis treatment. These enable effective and gentle blood cleansing, thereby improving the quality of life for dialysis patients. Another example of innovative products are the 3-in-1 infusion systems by Fresenius Kabi. These combine the administration of fluids, medications, and nutrition into one system, offering significantly higher efficiency in patient care. Fresenius Helios focuses on patient-centered care and offers a wide range of medical services. The company operates both acute care clinics and long-term care facilities and utilizes state-of-the-art technologies to improve diagnosis and treatment. Fresenius Vamed provides its customers with services such as facility management, planning, and project management for healthcare facilities, as well as operational consulting. The comprehensive expertise in all areas of the healthcare industry ensures high quality in the implementation of construction projects and renovations. In summary, Fresenius SE is an internationally active company specializing in the provision of high-quality products and services in the healthcare sector. The company focuses on patient-centered care and the continuous development of innovative products and technologies. Fresenius SE & Co KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.Fresenius SE & Co KGaA Käive segmendi järgi
Fresenius SE & Co KGaA aktsia (DE0005785604, 578560, FRE.DE) äriaruandes jagatakse käibed 4 segmendiks: 1. Helios, 2. Kabi, 3. Vamed, 4. Medical Care. Fresenius SE & Co KGaA aktsia (WKN: 578560, ISIN: DE0005785604, Ticker-Symbol: FRE.DE) on juhtiv investeering investoritele, kes on huvitatud osalemisest Health Care sektoris.
26 % Helios
19 % Kabi
5 % Vamed
50 % Medical Care
Sagedased küsimused Fresenius SE & Co KGaA aktsia kohta
Fresenius SE & Co KGaA aktsia on järgmiste pakkujate juures säästuplaaniga seotav: Trade Republic, ING, Scalable Capital ja Consorsbank
Andere Kennzahlen von Fresenius SE & Co KGaA
Meie Fresenius SE & Co KGaA Käive-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Fresenius SE & Co KGaA Käive. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse:
- Fresenius SE & Co KGaA Käive
- Fresenius SE & Co KGaA Kasum
- Fresenius SE & Co KGaA Kasumi ja hinna suhe
- Fresenius SE & Co KGaA KUV
- Fresenius SE & Co KGaA EBIT
- Fresenius SE & Co KGaA Dividend
- Fresenius SE & Co KGaA Aktsiad
- Fresenius SE & Co KGaA Turukapitalisatsioon
- Fresenius SE & Co KGaA Võlakoormus
- Fresenius SE & Co KGaA Kohustused
- Fresenius SE & Co KGaA Omakapital
- Fresenius SE & Co KGaA AAQS
- Fresenius SE & Co KGaA Töötajad
- Fresenius SE & Co KGaA ROE
- Fresenius SE & Co KGaA ROA
- Fresenius SE & Co KGaA ROCE